Journey Medical Corporation (DERM) vs Eledon Pharmaceuticals, Inc. (ELDN)
A side-by-side comparison of Journey Medical Corporation and Eledon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DERM
Journey Medical Corporation
$6.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ELDN
Eledon Pharmaceuticals, Inc.
$2.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DERM vs ELDN
growth of $100 · dividends reinvested · last 5yDERM -29.6% (-6.8%/yr)ELDN -50.4% (-13.1%/yr)DERM compounded faster over this window
DERM ELDN
DERM vs ELDN: by the numbers
- •ELDN is the larger company ($189M vs $170M market cap).
- •Both run net losses; ELDN's is the smaller (0.00% vs -8.95% net margin).
Metrics side by side
Valuation
| Metric | DERM | ELDN |
|---|---|---|
| P/S ratio | 2.49 | N/A |
| P/B ratio | 5.28 | 5.73 |
| EV / EBITDA | 134.26 | N/A |
Profitability
| Metric | DERM | ELDN |
|---|---|---|
| Gross margin | 62.24% | 0.00% |
| Operating margin | -13.21% | 0.00% |
| Net margin | -8.95% | 0.00% |
| ROE | -19.01% | -136.83% |
| ROIC | -5.22% | -74.02% |
Growth (annualized)
| Metric | DERM | ELDN |
|---|---|---|
| Revenue CAGR (5Y) | 6.75% | N/A |
| Total return CAGR (5Y) | N/A | -15.17% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.